Senior insider sale
EVP, CHIEF SCIENTIFIC OFFICER at EDITAS MEDICINE, INC. — senior position signals high conviction
$27.2K
8.23K shares
What this filing means
BURKLY LINDA plans to sell 8.23K shares of EDITAS MEDICINE, INC. valued at approximately $27.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/30/2025ACC: 0001650664-25-000110
Officer· EVP, CHIEF SCIENTIFIC OFFICER
Since Mar 2026
8.23K
Shares to sell
$27.2K
Approx. market value
11.29K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Vesting
Equity Compensation
7/30/2025
11.29KTotal acquired11.29K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/30/2025 | Restricted Stock Unit Vesting Equity Compensation | 11.29K | — |
| Total | 11.29K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
726.00
Market value
$1.3K
6/3/2025
Planned — Approximate Date
NasdaqPlanned
Units to sell
7.50K
Market value
$25.9K
7/31/2025
Total
Units
8.23K
Value
$27.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/3/2025 | 726.00 | $1.3K | — | Completed |
| Planned — Approximate Date | ||||
7/31/2025 | 7.50K | $25.9K | Nasdaq | Planned |
| Total | 8.23K | $27.2K | ||